Publication: SEOM clinical guideline in nasopharynx cancer (2017).
dc.contributor.author | Pastor, M | |
dc.contributor.author | Lopez Pousa, A | |
dc.contributor.author | Del Barco, E | |
dc.contributor.author | Perez Segura, P | |
dc.contributor.author | Astorga, B Gonzalez | |
dc.contributor.author | Castelo, B | |
dc.contributor.author | Bonfill, T | |
dc.contributor.author | Martinez Trufero, J | |
dc.contributor.author | Grau, J Jose | |
dc.contributor.author | Mesia, R | |
dc.date.accessioned | 2023-01-25T10:01:14Z | |
dc.date.available | 2023-01-25T10:01:14Z | |
dc.date.issued | 2017-11-02 | |
dc.description.abstract | Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiation therapy is an essential component of curative-intent of non-disseminated disease and the association of chemotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy and patients may achieve a long survival time. | |
dc.identifier.doi | 10.1007/s12094-017-1777-0 | |
dc.identifier.essn | 1699-3055 | |
dc.identifier.pmc | PMC5785612 | |
dc.identifier.pmid | 29098554 | |
dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785612/pdf | |
dc.identifier.unpaywallURL | https://link.springer.com/content/pdf/10.1007/s12094-017-1777-0.pdf | |
dc.identifier.uri | http://hdl.handle.net/10668/11764 | |
dc.issue.number | 1 | |
dc.journal.title | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | |
dc.journal.titleabbreviation | Clin Transl Oncol | |
dc.language.iso | en | |
dc.organization | Hospital Universitario San Cecilio | |
dc.page.number | 84-88 | |
dc.pubmedtype | Journal Article | |
dc.pubmedtype | Practice Guideline | |
dc.rights | Attribution 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | Locally-advanced disease | |
dc.subject | Nasopharynx cancer | |
dc.subject | Recurrent/metastatic disease | |
dc.subject | Treatment guidelines | |
dc.subject.mesh | Carcinoma | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Nasopharyngeal Carcinoma | |
dc.subject.mesh | Nasopharyngeal Neoplasms | |
dc.title | SEOM clinical guideline in nasopharynx cancer (2017). | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 20 | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1